February 19, 2026 08:05 ET | Source: GigaCloud Technology EL MONTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology…
Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital pathology February 17, 2026 08:00 ET | Source:…
Cash and cash equivalents at €99.3 million, and €131.6 million in short-term deposits2 as of December 31, 2025Revenues of €4.5…
February 13, 2026 16:30 ET | Source: Natural Alternatives International Inc CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural…
US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million NIAID Funding Award Supports VXV-01 Development Through Phase…
50-year study of the US market and 20 years of foreign market data informs components of market value.NEW YORK, Feb.…
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces the financial results for the fourth quarter and…
Exceeding latest 2025 guidance following a strong performance from both commercial arms of the business in Travel Health and Public…
Total ARR grew 21% to $480.8 million; Revenue grew 18% to $128.8 million Net income of $21.3 million supports non-GAAP net…
February 11, 2026 06:00 ET | Source: Upstream Bio – Verekitug provided statistically significant and clinically meaningful reductions in annualized…